These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 21438666)

  • 21. Association between apolipoprotein A5 - 1131T > C polymorphism and susceptibility of coronary artery disease in Chinese.
    Tang YB; Sun P; Guo DP; Li XY; Chen Q; Fan LM
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Jun; 22(3):281-3. PubMed ID: 15952115
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Apolipoprotein E E3/E4 genotype is associated with an increased risk of type 2 diabetes mellitus complicated with coronary artery disease.
    Chen W; Li B; Wang H; Wei G; Chen K; Wang W; Wang S; Liu Y
    BMC Cardiovasc Disord; 2024 Mar; 24(1):160. PubMed ID: 38491412
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of polymorphisms in APOA5 on the plasma levels of triglycerides and risk of coronary heart disease in Jilin, northeast China: a case-control study.
    You Y; Wu YH; Zhang Y; Zhang L; Song Y; Bai W; Li Y; Yu Y; Kou C
    BMJ Open; 2018 Jun; 8(6):e020016. PubMed ID: 29866721
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Paraoxonase-1 is not associated with coronary artery calcification in type 2 diabetes: results from the PREDICT study.
    Mackness B; Marsillach J; Elkeles RS; Godsland IF; Feher MD; Rubens MB; Flather MD; Humphries SE; Cooper J; Mackness M
    Dis Markers; 2012; 33(2):101-12. PubMed ID: 22846213
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PON1 L55M and Q192R gene polymorphisms and CAD risks in patients with hyperlipidemia : Clinical study of possible associations.
    Chen H; Ding S; Zhou M; Wu X; Liu X; Liu J; Wu Y; Liu D
    Herz; 2018 Nov; 43(7):642-648. PubMed ID: 28835968
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship of APOA5, PPARγ and HL gene variants with serial changes in childhood body mass index and coronary artery disease risk factors in young adulthood.
    Ramakrishnan L; Sachdev HS; Sharma M; Abraham R; Prakash S; Gupta D; Singh Y; Bhaskar S; Sinha S; Chandak GR; Reddy KS; Santosh B
    Lipids Health Dis; 2011 May; 10():68. PubMed ID: 21548985
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CDKN2B-AS (rs2891168), SOD2 (rs4880), and PON1 (rs662) polymorphisms and susceptibility to coronary artery disease and type 2 diabetes mellitus in Iranian patients: A case-control study.
    Yari A; Karam ZM; Meybodi SME; Sargazi ML; Saeidi K
    Health Sci Rep; 2023 Nov; 6(11):e1717. PubMed ID: 38028681
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic basis of dyslipidemia in disease precipitation of coronary artery disease (CAD) associated type 2 diabetes mellitus (T2DM).
    Raj R; Bhatti JS; Badada SK; Ramteke PW
    Diabetes Metab Res Rev; 2015 Oct; 31(7):663-71. PubMed ID: 25470794
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Association of APOA5-1131T>C polymorphism with obesity in coronary artery disease].
    Çoban N; Özuynuk AS; Erkan AF; Ekici B; Kaşit M; Erginel Ünaltuna N
    Turk Kardiyol Dern Ars; 2020 Jul; 48(5):461-471. PubMed ID: 32633266
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Paraoxonase-1 Q192R polymorphism and its association with hs-CRP and fasting blood glucose levels and risk of coronary artery disease.
    Amini M; Esmaeilzadeh-Bahabadi S; Avan A; Gholoobi A; Ghasemi F; Mirhafez SR; Ghazizadeh H; Moohebati M; Ebrahimi M; Ferns GA; Pasdar A; Mobarhan MG
    Diabetes Metab Syndr; 2019; 13(2):1053-1057. PubMed ID: 31336443
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PON1 L55M polymorphism is not a predictor of coronary atherosclerosis either alone or in combination with Q192R polymorphism in an Italian population.
    Arca M; Ombres D; Montali A; Campagna F; Mangieri E; Tanzilli G; Campa PP; Ricci G; Verna R; Pannitteri G
    Eur J Clin Invest; 2002 Jan; 32(1):9-15. PubMed ID: 11851721
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Apo A5 -1131T/C, FgB -455G/A, -148C/T, and CETP TaqIB gene polymorphisms and coronary artery disease in the Chinese population: a meta-analysis of 15,055 subjects.
    Li YY; Wu XY; Xu J; Qian Y; Zhou CW; Wang B
    Mol Biol Rep; 2013 Feb; 40(2):1997-2014. PubMed ID: 23129316
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Q192R polymorphism of the paraoxonase 1 gene is a risk factor for coronary artery disease in Saudi subjects.
    Hassan MA; Al-Attas OS; Hussain T; Al-Daghri NM; Alokail MS; Mohammed AK; Vinodson B
    Mol Cell Biochem; 2013 Aug; 380(1-2):121-8. PubMed ID: 23625196
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Paraoxonase 1 (PON1) L55M and Q192R polymorphisms are not associated with chronic kidney disease in Thai individuals with type 2 diabetes.
    Nawaka N; Pansang P; Saniwa A; Chaibut N; Jeenduang N
    Int J Clin Pract; 2021 Dec; 75(12):e14982. PubMed ID: 34637171
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Both paraoxonase-1 genotype and activity do not predict the risk of future coronary artery disease; the EPIC-Norfolk Prospective Population Study.
    Birjmohun RS; Vergeer M; Stroes ES; Sandhu MS; Ricketts SL; Tanck MW; Wareham NJ; Jukema JW; Kastelein JJ; Khaw KT; Boekholdt SM
    PLoS One; 2009 Aug; 4(8):e6809. PubMed ID: 19710913
    [TBL] [Abstract][Full Text] [Related]  

  • 36. APOA5 -1131T/C polymorphism is associated with coronary artery disease in a Chinese population: a meta-analysis.
    Zhai G; Li M; Zhu C
    Clin Chem Lab Med; 2011 Mar; 49(3):535-9. PubMed ID: 21143013
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Apolipoprotein A5 gene polymorphism -1131T-->C: association with plasma lipids and type 2 diabetes mellitus with coronary heart disease in Chinese.
    Yan SK; Cheng XQ; Song YH; Xiao XH; Bi N; Chen BS
    Clin Chem Lab Med; 2005; 43(6):607-12. PubMed ID: 16006256
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PON1 M/L55 mutation protects high-risk patients against coronary artery disease.
    Oliveira SA; Mansur AP; Ribeiro CC; Ramires JA; Annichino-Bizzacchi JM
    Int J Cardiol; 2004 Mar; 94(1):73-7. PubMed ID: 14996478
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic association of Glutathione peroxidase-1 (GPx-1) and NAD(P)H:Quinone Oxidoreductase 1(NQO1) variants and their association of CAD in patients with type-2 diabetes.
    Ramprasath T; Murugan PS; Kalaiarasan E; Gomathi P; Rathinavel A; Selvam GS
    Mol Cell Biochem; 2012 Feb; 361(1-2):143-50. PubMed ID: 21989715
    [TBL] [Abstract][Full Text] [Related]  

  • 40. -1131T>C and SW19 polymorphisms in APOA5 gene and lipid levels in type 2 diabetic patients.
    Sóter MO; Gomes KB; Fernandes AP; Carvalho Md; Pinheiro PS; Bosco AA; Silva DD; Sousa MO
    Mol Biol Rep; 2012 Jul; 39(7):7541-8. PubMed ID: 22350263
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.